70 related articles for article (PubMed ID: 32897196)
1. [Serum level of lncRNA TUSC7 in patients with esophageal squamous cell carcinoma and its role in promoting tumor cell migration and invasion].
Zhao K; Guo Y; Huo Z; Ma G; Zhang G; Xing Y; Xu Q
Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):661-669. PubMed ID: 32897196
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of RCN1 inhibits esophageal squamous cell carcinoma progression and M2 macrophage polarization.
Guo H; Shu J; Hu G; Liu B; Li J; Sun J; Wang X; Liu H; Xiong S; Tang Y; Yin Y; Wang X
PLoS One; 2024; 19(5):e0302780. PubMed ID: 38713738
[TBL] [Abstract][Full Text] [Related]
3. MBIP promotes ESCC metastasis by activating MAPK pathway.
Ma Y; Hua Y; Yin X; Jiao Y; Xu E; Yan T; Yang J; Zhang L
Cell Signal; 2024 Mar; 115():111040. PubMed ID: 38199596
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
Ke K; Sun Z; Wang Z
Oncol Lett; 2018 Aug; 16(2):1801-1808. PubMed ID: 30008868
[TBL] [Abstract][Full Text] [Related]
5. IL-1RA inhibits esophageal carcinogenesis and lymphangiogenesis via downregulating VEGF-C and MMP9.
Shen Z; Zhang P; Zhang W; Luo F; Xu H; Chen S; Kang M
Funct Integr Genomics; 2023 May; 23(2):164. PubMed ID: 37198330
[TBL] [Abstract][Full Text] [Related]
6. Single-cell transcriptomic analysis reveals the landscape of epithelial-mesenchymal transition molecular heterogeneity in esophageal squamous cell carcinoma.
Guo D; Sheng K; Zhang Q; Li P; Sun H; Wang Y; Lyu X; Jia Y; Wang C; Wu J; Zhang X; Wang D; Sun Y; Huang S; Yu J; Zhang J
Cancer Lett; 2024 Apr; 587():216723. PubMed ID: 38342234
[TBL] [Abstract][Full Text] [Related]
7. Fractionated irradiation-induced EMT-like phenotype conferred radioresistance in esophageal squamous cell carcinoma.
Zhang H; Luo H; Jiang Z; Yue J; Hou Q; Xie R; Wu S
J Radiat Res; 2016 Jul; 57(4):370-80. PubMed ID: 27125498
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy.
Shi Q; Shen L; Dong B; Fu H; Kang X; Dai L; Yang Y; Yan W; Chen KN
Thorac Cancer; 2018 Jul; 9(7):836-846. PubMed ID: 29757528
[TBL] [Abstract][Full Text] [Related]
9. Tissue-based quantitative proteomics to screen and identify the potential biomarkers for early recurrence/metastasis of esophageal squamous cell carcinoma.
Cai XW; Yu WW; Yu W; Zhang Q; Feng W; Liu MN; Sun MH; Xiang JQ; Zhang YW; Fu XL
Cancer Med; 2018 Jun; 7(6):2504-2517. PubMed ID: 29683265
[TBL] [Abstract][Full Text] [Related]
10. LincRNA-P21 knockdown facilitates esophageal squamous cell carcinoma cell progression by upregulating cadherin 5 via YTH domain containing 1.
Wang J; Zhu L; Zhang Q; Xia T; Yao W; Wei L
Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1797-1805. PubMed ID: 37766459
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the correlativity of gender determining region Y-box 4, N-cadherin, CD44 and E-cadherin expression in the prognosis of esophageal squamous cell carcinoma.
Qin Y; Zhao W; Cheng L; Gao J; Bian Z; Wu S; Cheng Z; Tao Y; Ma L
Int J Clin Exp Pathol; 2019; 12(5):1745-1756. PubMed ID: 31933993
[TBL] [Abstract][Full Text] [Related]
12. Effect of Linc-POU3F3 on radiotherapy resistance and cancer stem cell markers of esophageal cancer cells.
Chen Y; Tang J; Li L; Lu T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 46(6):583-590. PubMed ID: 34275926
[TBL] [Abstract][Full Text] [Related]
13. NEK2 promotes the migration, invasion, proliferation of ESCC and mediates ESCC immunotherapy.
Gu S; Yasen Y; Wang M; Huang B; Zhou Y; Wang W
Heliyon; 2024 May; 10(9):e29682. PubMed ID: 38707418
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Risk Models Using Epithelial Cells Identify β-Sitosterol as a Potential Therapeutic Target Against Esophageal Squamous Cell Carcinoma.
Zhang Z; Shang B; Mao X; Shi Y; Zhang G; Wang D
Int J Gen Med; 2024; 17():1193-1211. PubMed ID: 38559590
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis and experimental verification of NLRX1 as a prognostic factor for esophageal squamous cell carcinoma.
Zhou L; Gan L; Sun C; Chu A; Yang M; Liu Z
Oncol Lett; 2024 Jun; 27(6):264. PubMed ID: 38659420
[TBL] [Abstract][Full Text] [Related]
16. CD90 positive cells exhibit aggressive radioresistance in esophageal squamous cell carcinoma.
Wang Y; Zhang C; Zhu H; Tang J; Zhang S; Luo J; Sun X
J Thorac Dis; 2017 Mar; 9(3):610-620. PubMed ID: 28449469
[TBL] [Abstract][Full Text] [Related]
17. Chloride intracellular channel 1 as a switch among tumor behaviors in human esophageal squamous cell carcinoma.
Kobayashi T; Shiozaki A; Nako Y; Ichikawa D; Kosuga T; Shoda K; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Marunaka Y; Otsuji E
Oncotarget; 2018 May; 9(33):23237-23252. PubMed ID: 29796185
[No Abstract] [Full Text] [Related]
18. Biofunctional study on chemoresistance in esophageal squamous carcinoma cells induced by missense mutation of
Li K; Hao W; Wu J; Liu X; Xing W; Zheng Y
J Thorac Dis; 2024 Mar; 16(3):1947-1959. PubMed ID: 38617785
[TBL] [Abstract][Full Text] [Related]
19. Local and Systemic Interleukin-32 in Esophageal, Gastric, and Colorectal Cancers: Clinical and Diagnostic Significance.
Diakowska D; Krzystek-Korpacka M
Diagnostics (Basel); 2020 Oct; 10(10):. PubMed ID: 33020452
[TBL] [Abstract][Full Text] [Related]
20. [Retracted] Downregulation of long non‑coding RNA GAS5 promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
Ke K; Sun Z; Wang Z
Oncol Lett; 2024 Jun; 27(6):239. PubMed ID: 38623571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
